Market Overview

Auxilium Pharmaceuticals and FCB I File Lawsuit Against Watson for Infringement of Testim Patents

Related AUXL
R.F. Lafferty Devalues Auxilium, QLT Deal
Auxilium And QLT To Merge On Tax Saving Attractions - Analyst Blog

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and FCB I LLC announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc. (NYSE: WPI); and Watson Pharma, Inc. for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations as covering TestimĀ® 1% testosterone gel.

The lawsuit was filed in the United States District Court for the District of New Jersey on May 23, 2012.

Posted-In: News FDA Legal


Most Popular

Related Articles (AUXL + WPI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters